Your session is about to expire
← Back to Search
mPATH-CRC for Colorectal Cancer
N/A
Waitlist Available
Led By David Miller, MD, MS
Research Sponsored by Wake Forest University Health Sciences
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up months 7-12
Awards & highlights
Study Summary
This trial is testing a new iPad program to see if it is effective in clinical practice.
Eligible Conditions
- Colorectal Cancer
- Colon Cancer
- Cancer
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ months 7-12
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~months 7-12
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Percent of Patients Who Complete the mPATH-CRC Program
Secondary outcome measures
CRC Screening Tests Ordered
Facilitators and Barriers to Maintenance (Sustained Use of mPATH-CRC Over Time)
mPATH-CRC Acceptability
+14 moreTrial Design
8Treatment groups
Experimental Treatment
Group I: Clinic personnel on "low touch" Strategy (Post-Implementation)Experimental Treatment3 Interventions
Clinic personnel (e.g., administrators, nurses, providers) who are involved with the implementation of mPATH-CRC, in the study clinics randomized to mPATH utilizing the "low touch" implementation strategy in the 12 months after implementation.
Group II: Clinic personnel on "high touch" Strategy (Post-Implementation)Experimental Treatment3 Interventions
Clinic personnel (e.g., administrators, nurses, providers) who are involved with the implementation of mPATH-CRC, in the study clinics randomized to mPATH utilizing the "high touch" implementation strategy in the 12 months after implementation.
Group III: Clinic Patients Eligible for CRC Screening on "low touch" Strategy (Pre-Implementation)Experimental Treatment1 Intervention
English or Spanish-speaking patients aged 50-74 who are eligible for CRC screening who are seen in the study clinics randomized to mPATH utilizing the "low touch" implementation strategy but in 8 months before implementation.
Group IV: Clinic Patients Eligible for CRC Screening on "low touch" Strategy (Post-Implementation)Experimental Treatment3 Interventions
English or Spanish-speaking patients aged 50-74 who are eligible for CRC screening who are seen in the study clinics randomized to mPATH utilizing the "low touch" implementation strategy in the 12 months after implementation.
Group V: Clinic Patients Eligible for CRC Screening on "high touch" Strategy (Pre-Implementation)Experimental Treatment1 Intervention
English or Spanish-speaking patients aged 50-74 who are eligible for CRC screening who are seen in the study clinics randomized to mPATH utilizing the "high touch" implementation strategy but in 8 months before implementation.
Group VI: Clinic Patients Eligible for CRC Screening on "high touch" Strategy (Post-Implementation)Experimental Treatment3 Interventions
English or Spanish-speaking patients aged 50-74 who are eligible for CRC screening who are seen in the study clinics randomized to mPATH utilizing the "high touch" implementation strategy in the 12 months after implementation.
Group VII: All Adult Clinic Patients on "low touch" Strategy (Post-Implementation)Experimental Treatment2 Interventions
English or Spanish-speaking patients aged 18 or older who are seen in the study clinics randomized to mPATH utilizing the "low touch" implementation strategy in the 12 months after implementation.
Group VIII: All Adult Clinic Patients on "high touch" Strategy (Post-Implementation)Experimental Treatment2 Interventions
English or Spanish-speaking patients aged 18 or older who are seen in the study clinics randomized to mPATH utilizing the "high touch" implementation strategy in the 12 months after implementation.
Find a Location
Who is running the clinical trial?
National Cancer Institute (NCI)NIH
13,657 Previous Clinical Trials
40,856,522 Total Patients Enrolled
Wake Forest University Health SciencesLead Sponsor
1,240 Previous Clinical Trials
927,062 Total Patients Enrolled
David Miller, MD, MSPrincipal InvestigatorWake Forest University Health Sciences
2 Previous Clinical Trials
24,026 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is enrollment for this trial currently accessible to participants?
"This clinical trial is actively seeking participants. The study was initially posted on October 31st 2019, with the most recent edit being made on May 4th 2022."
Answered by AI
How many individuals have joined this research project?
"Affirmative. Information published on clinicaltrials.gov elucidates that this trial is ongoing, beginning October 31st 2019 and most recently updated May 4th 2022. This research requires 150000 patients from a single site to be enrolled."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger